KTU chemists develop dual-action compounds to fight cancer and infections

Publisher Correction: Targeting cancer-specific mutations with RNA-triggered chromatin shredding

New Imaging Technology Tracks Cancer From the Whole Body to Single Cells

New Drug Turns Cancer’s Favorite Fuel Into a Deadly Weakness